GlycoGrip – Connecting the Dots to Disease Detection

GlycoGrip – A Straight Line to Disease Detection Stopping viral disease spread relies on accurate, cost efficient and robust community detection. Multiplexed tools that are responsive to viral mutations remove the need for iterative devices, and equip public health practitioners with test-to-treat tools that detect infection at early stages of disease, and stop an outbreak before it begins.   … Continue reading GlycoGrip – Connecting the Dots to Disease Detection

All That Glitters – Sensors From the Lab to Field

Translating sensors from the lab benchtop to a readily available point-of-need setting is desirable for many fields, including medicine, agriculture, and industry. However, this transition generally suffers from loss of sensitivity, high background signals, and other issues which can impair reproducibility. Here we adapt a label-free surface-enhanced Raman spectroscopy (SERS) sensor for SARS-CoV-2 antigens from… Continue reading All That Glitters – Sensors From the Lab to Field

Freeman Lab featured on Front Cover of Carolina scientific magazine

Ronit Freeman and the Freeman Lab were featured on the cover of Carolina Scientific, a quarterly research magazine, published by The University of North Carolina (UNC) Chapel Hill.  Carolina Scientific highlighted the Freeman Lab’s innovative and cost-effective GlycoGrip test strip, which is an alternative to the RT-PCR testing method used in laboratories to test for the presence of COVID-19… Continue reading Freeman Lab featured on Front Cover of Carolina scientific magazine

NSF Director features Freeman Lab’s COVID-19 testing breakthrough in NSF Quarterly Newsletter

The newly appointed NSF Director has featured the Freeman Lab in his first quarterly NSF newsletter. In this impactful piece, the NSF shines a light on how researchers at the Freeman Lab designed a rapid sensing COVID-19 test to meet the challenge of tracking variants, with a sugar-coated strip advances COVID-19 testing. Read the full… Continue reading NSF Director features Freeman Lab’s COVID-19 testing breakthrough in NSF Quarterly Newsletter